Senior insider sale
TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$855.5K
168.08K shares
What this filing means
NOLAN SEAN P. plans to sell 168.08K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $855.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/23/2026ACC: 0001569926-26-000006
168.08K
Shares to sell
$855.5K
Approx. market value
168.08K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
1/23/2026
168.08KTotal acquired168.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 168.08K | — |
| Total | 168.08K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
168.08K
Market value
$855.5K
1/23/2026
Total
Units
168.08K
Value
$855.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/23/2026 | 168.08K | $855.5K | Nasdaq | Planned |
| Total | 168.08K | $855.5K | ||